Pandemic's Workshop ; Making Policy, Making Money, Making Vaccine
The Washington Times › December 07, 2009
Linked as:
Summary
The cost of the nation's strategy to protect its citizens from a global flu pandemic has been substantial. And, its critics claim, hundreds of millions have been misspent in the effort - largely in support of highly profitable multinational drug companies.
The benefit, most observers say, has been that despite delays in swine-flu vaccine production, the national policy helped the government respond more quickly to a major public-health threat than ever before.See the full content of this document
Extract
Pandemic's Workshop ; Making Policy, Making Money, Making Vaccine
Taxpayer-funded research aided companies developing new vaccines, and foreign drug giants were given hundreds of millions to build vaccine plants in the United States. The government also committed to pay vaccine makers billions more to guarantee a supply for Americans.
Without such a global, public-private enterprise, the nation would have lacked an established infrastructure to respond effectively to the swine-flu outbreak, said Michael T. Osterholm, director of the Center for...See the full content of this document
Sponsored links
